| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $0 | — | -100.0% |
| R&D Expense | $5.4M | -32.2% | -51.6% |
| SG&A Expense | $5.2M | -66.4% | -61.5% |
| Operating Income | -$15.1M | +35.4% | -60.6% |
| Pre-tax Income | -$14.6M | +30.8% | -80.1% |
| Income Tax | -$71K | -184.0% | -2266.7% |
| Net Income | -$14.6M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $74.3M | -13.9% | — |
| Current Assets | $86.8M | -13.6% | -35.6% |
| Total Assets | $109.2M | -15.7% | -42.1% |
| Current Liabilities | $10.8M | -15.1% | -28.4% |
| Total Liabilities | $24.6M | -9.0% | -15.7% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$43.7M | — | — |
| Capital Expenditures | $37K | — | — |
| Investing Cash Flow | $414K | — | — |
| Financing Cash Flow | $2K | — | — |
| Free Cash Flow | -$43.8M | — | — |
| -79.5% |
| EPS (Basic) | -$0.36 | +30.8% | -71.4% |
| EPS (Diluted) | -$0.36 | +30.8% | -71.4% |
| $84.5M |
| -17.5% |
| -47.0% |